All regenerative medicine procedures performed at Rejuvenate Medical Group are performed using allogenic products sourced from the Wharton’s Jelly layer of the umbilical cord and amniotic fluid and amnio tissue from healthy, full-term donors which is Regulated by the United States Food and Drug Administration as Human Cells, Tissues, Cellular and Tissue-Based Products (HCT/P’s) under Section 361.The healthcare practitioner performs therapies that have not yet been approved by the United States Food and Drug Administration. You are encouraged to consult with your primary care physician prior to undergoing regenerative medicine therapy.